LFCR
HealthcareLifecore Biomedical, Inc.
$7.80
+$0.06 (+0.78%)
Jan 5, 2026
Price History (1Y)
Analysis
Lifecore Biomedical, Inc. is a company in the Healthcare sector, operating within the Drug Manufacturers - Specialty & Generic industry. It has a market capitalization of $292.24M and generates revenue of approximately $128.87M (TTM), employing 406 individuals. The company's financial health indicates significant losses, with net income totaling -$44,359,000 (TTM) and EBITDA at -$3,979,000. Free cash flow is also negative, standing at -$28,833,624. Despite this, the company maintains a relatively healthy cash position of $18.86M, but has substantial debt of $137.53M, resulting in a high debt-to-equity ratio of 373.87. The valuation context for Lifecore Biomedical, Inc. is marked by negative earnings growth rates (N/A) and a forward P/E ratio of -9.07. The company's price to book ratio stands at 216.67, while its price to sales ratio is 2.27. The dividend yield is N/A, and the payout ratio is 0.0%.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Lifecore Biomedical, Inc.
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacture of hyaluronate acid in bulk form; and formulated and filled syringes, cartridges, and vials for injectable products used in treating a range of medical conditions and procedures. It also provides product development services include analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and production of materials for clinical studies. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.
Visit website →Key Statistics
- Market Cap
- $292.24M
- P/E Ratio
- N/A
- 52-Week High
- $8.85
- 52-Week Low
- $4.76
- Avg Volume
- 167.14K
- Beta
- 0.59
Company Info
- Exchange
- NMS
- Country
- United States
- Employees
- 406